Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.859
Revised: August 27, 2014
Accepted: October 14, 2014
Published online: December 16, 2014
Core tip: Allergen specific immuntherapy is the only therapeutic approach that can change the immunologic response to allergens and thus can alter the natural evolution of allergic diseases. Both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) have been demonstrated to be beneficial in reducing of symptoms and drug intake,improving quality of life and preventing patients from possible side effects of high doses of steroids. This review examines the clinical effectiveness and safety of both SCIT and SLIT in patients with asthma by discussing recent studies.